Bio-Path Holdings Inc
BPTH
BPTH was delisted on the 18th of February, 2025.
29 hedge funds and large institutions have $2.73M invested in Bio-Path Holdings Inc in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 0 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
12% more funds holding
Funds holding: 26 → 29 (+3)
32% less capital invested
Capital invested by funds: $3.98M → $2.73M (-$1.26M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$589K |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$432K |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$249K |
| 4 |
Renaissance Technologies
New York
|
+$86.2K |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$32.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
-$431K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$107K |
| 3 |
Millennium Management
New York
|
-$84.9K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$15.4K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$6.43K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $3K | – | – | – |
|
27
Bank of America
Charlotte,
North Carolina
| $2K | – | – | – |
|
28
Goldman Sachs
New York
| $2K | – | – | – |
|
|
MAM
29
Meeder Asset Management
Dublin,
Ohio
| $1K | – | – | – |
|
30
BNP Paribas Financial Markets
Paris,
France
| – | -$7 | – | – |
|
BPTH Hedge Fund Activity: Q4 2017 in Review
29 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q4 2017, worth a combined $2.73M — down 32% from $3.98M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BPTH positions and 0 closed out — a net gain of 3 holders — while 8 added to existing stakes and 6 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $589K. The largest seller was HighTower Advisors, cutting an estimated $431K.
- 29 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q4 2017, up from 26 in Q3 2017.
- Funds reported $2.73M of Bio-Path Holdings Inc stock for Q4 2017, down 32% quarter-over-quarter.
- 3 funds opened new Bio-Path Holdings Inc positions in Q4 2017 and 0 closed out, a net change of +3 holders.
- The largest Bio-Path Holdings Inc buyer in Q4 2017 was Sabby Management, an estimated $589K added.
- The largest Bio-Path Holdings Inc seller in Q4 2017 was HighTower Advisors, an estimated $431K sold.
Based on aggregated 13F filings for Q4 2017.